BlueWillow Biologics, Inc.

BlueWillow Biologics, Inc.

Biotechnology Research

BlueWillow Biologics® is developing and enabling a new generation of nasal vaccines.

About us

BlueWillow Biologics® is developing and enabling a new generation of safe and effective nasal vaccines to protect global populations from respiratory infections, sexually transmitted diseases, and food allergies. Our novel intranasal NanoVax® adjuvant platform activates mucosal immunity, the body’s first line of defense, while also inducing systemic immunity. We are a clinical-stage company advancing a pipeline of proprietary programs including Peanut Allergy, HSV-2, Covid-19, Anthrax, Pandemic Flu and RSV.

Industry
Biotechnology Research
Company size
11-50 employees
Type
Privately Held

Locations

Employees at BlueWillow Biologics, Inc.

Updates

Similar pages

Browse jobs